You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Cenci Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for CENCI, and what generic and branded alternatives to CENCI drugs are available?

CENCI has twelve approved drugs.



Summary for Cenci
US Patents:0
Tradenames:12
Ingredients:9
NDAs:12

Drugs and US Patents for Cenci

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cenci ELIXOMIN theophylline ELIXIR;ORAL 088303-001 Jan 25, 1984 DISCN No No ⤷  Subscribe ⤷  Subscribe
Cenci THEOPHYLLINE theophylline ELIXIR;ORAL 087679-001 Apr 15, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe
Cenci HYDROCORTISONE ACETATE hydrocortisone acetate CREAM;TOPICAL 080419-001 Jan 25, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe
Cenci HISTAFED pseudoephedrine hydrochloride; triprolidine hydrochloride SYRUP;ORAL 088283-001 Apr 20, 1984 DISCN No No ⤷  Subscribe ⤷  Subscribe
Cenci PROMETHAZINE VC PLAIN phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 088815-001 Nov 22, 1985 DISCN No No ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.